Search

everythinglearnresearchcommunity

for

Search:↓

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Cyproterone acetate works similarly to other treatments for hirsutism, but more research is needed.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Oral bicalutamide is safe and effective for female hair loss.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Upadacitinib improved multiple immune-related conditions in one patient.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

New compounds were made that are promising for prostate cancer therapy.

CS12192 effectively treats alopecia areata with better safety than current options.